Found: 12
Select item for more details and to access through your institution.
Accuracy of epidermal growth factor receptor gene mutation analysis by direct sequencing method based on small biopsy specimens from patients with non-small cell lung cancer: analysis of results in 19 patients.
- Published in:
- International Journal of Clinical Oncology, 2008, v. 13, n. 5, p. 442, doi. 10.1007/s10147-008-0772-4
- By:
- Publication type:
- Article
Clinicopathologic Factors Affecting the Progression-Free Survival of Patients With Advanced Non-Small-Cell Lung Cancer After Gefitinib Therapy.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 1, p. 56, doi. 10.3816/CLC.2011.n.008
- By:
- Publication type:
- Article
Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 2, p. 325, doi. 10.1007/s00280-010-1321-1
- By:
- Publication type:
- Article
Should Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Be Continued beyond Progressive Disease?
- Published in:
- Case Reports in Oncology, 2011, v. 4, n. 3, p. 470, doi. 10.1159/000332758
- By:
- Publication type:
- Article
Outcome of Surgical Treatment for Metastatic Vertebra Bone Tumor in Advanced Lung Cancer.
- Published in:
- Case Reports in Oncology, 2010, v. 3, n. 1, p. 63, doi. 10.1159/000299385
- By:
- Publication type:
- Article
Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 4, p. 819, doi. 10.1002/cncr.25618
- By:
- Publication type:
- Article
Clinical Significance of Pretreatment C-Reactive Protein in Patients with Advanced Nonsquamous, Non-Small Cell Lung Cancer Who Received Gefitinib.
- Published in:
- Oncology, 2011, v. 79, n. 5/6, p. 355, doi. 10.1159/000323486
- By:
- Publication type:
- Article
Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.
- Published in:
- Cancer Science, 2009, v. 100, n. 10, p. 1917, doi. 10.1111/j.1349-7006.2009.01253.x
- By:
- Publication type:
- Article
Clinical significance of pretreatment serum amphiregulin and transforming growth factor-α, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer.
- Published in:
- Cancer Science, 2008, v. 99, n. 11, p. 2295, doi. 10.1111/j.1349-7006.2008.00931.x
- By:
- Publication type:
- Article
Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor.
- Published in:
- Medical Oncology, 2012, v. 29, n. 1, p. 185, doi. 10.1007/s12032-010-9764-0
- By:
- Publication type:
- Article
Clinical significance of the ratio between the alpha 2 plasmin inhibitor-plasmin complex and the thrombin-antithrombin complex in advanced non-small cell lung cancer.
- Published in:
- Medical Oncology, 2011, v. 28, n. 1, p. 351, doi. 10.1007/s12032-010-9454-y
- By:
- Publication type:
- Article
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancerpatients treated with platinum-based doubletc hemotherapy.
- Published in:
- BMC Medical Genetics, 2010, v. 11, p. 167, doi. 10.1186/1471-2350-11-167
- By:
- Publication type:
- Article